Business Description
Apontis Pharma AG
ISIN : DE000A3CMGM5
Share Class Description:
FRA:APPH: Bearer SharesTotal Employee Number:
137Compare
Compare
Traded in other countries / regions
APPH.Germany IPO Date
2021-05-11Description
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.72 | |||||
Interest Coverage | 30.8 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.44 | |||||
Beneish M-Score | -2.33 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.1 | |||||
3-Year EBITDA Growth Rate | 14.9 | |||||
3-Year Book Growth Rate | -8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 137.34 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 19.64 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 73.64 | |||||
9-Day RSI | 68.3 | |||||
14-Day RSI | 64.7 | |||||
3-1 Month Momentum % | -0.47 | |||||
6-1 Month Momentum % | -4.11 | |||||
12-1 Month Momentum % | 10.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.78 | |||||
Quick Ratio | 5.63 | |||||
Cash Ratio | 4.06 | |||||
Days Inventory | 104.08 | |||||
Days Sales Outstanding | 7.93 | |||||
Days Payable | 72.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.7 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.16 | |||||
Operating Margin % | 2.08 | |||||
Net Margin % | 1.27 | |||||
EBITDA Margin % | 5.63 | |||||
FCF Margin % | -9.3 | |||||
OCF Margin % | -1.89 | |||||
ROE % | 2.1 | |||||
ROA % | 1.44 | |||||
ROIC % | 2.44 | |||||
ROC (Joel Greenblatt) % | 21.89 | |||||
ROCE % | 2.74 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 141.03 | |||||
Forward PE Ratio | 11.42 | |||||
PE Ratio without NRI | 141.03 | |||||
PS Ratio | 1.77 | |||||
PB Ratio | 2.9 | |||||
Price-to-Tangible-Book | 7.28 | |||||
EV-to-EBIT | 67.89 | |||||
EV-to-EBITDA | 26.14 | |||||
EV-to-Revenue | 1.47 | |||||
EV-to-FCF | -15.83 | |||||
Price-to-GF-Value | 1.05 | |||||
Price-to-Graham-Number | 6.75 | |||||
| Price-to-Net-Current-Asset-Value | 9.73 | |||||
Earnings Yield (Greenblatt) % | 1.47 | |||||
FCF Yield % | -5.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apontis Pharma AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 51.774 | ||
| EPS (TTM) (€) | 0.078 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.51 | ||
| Volatility % | 11.14 | ||
| 14-Day RSI | 64.7 | ||
| 14-Day ATR (€) | 0.162063 | ||
| 20-Day SMA (€) | 10.735 | ||
| 12-1 Month Momentum % | 10.76 | ||
| 52-Week Range (€) | 9.34 - 12.2 | ||
| Shares Outstanding (Mil) | 8.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apontis Pharma AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apontis Pharma AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Apontis Pharma AG Frequently Asked Questions
What is Apontis Pharma AG(FRA:APPH)'s stock price today?
The current price of FRA:APPH is €11.00. The 52 week high of FRA:APPH is €12.20 and 52 week low is €9.34.
When is next earnings date of Apontis Pharma AG(FRA:APPH)?
The next earnings date of Apontis Pharma AG(FRA:APPH) is .
Does Apontis Pharma AG(FRA:APPH) pay dividends? If so, how much?
Apontis Pharma AG(FRA:APPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Apontis Pharma AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers